news
Stopping beta-blockers after heart attack may be safe
A Lancet comment piece argues that routine, indefinite beta-blocker prescriptions after a heart attack might be outdated. Current treatments like statins and antiplatelets have changed outcomes, suggesting many patients could safely stop beta-blockers years later without increased risk.
A Lancet comment piece argues that routine, indefinite beta-blocker prescriptions after a heart attack might be outdated. Current treatments like statins and antiplatelets have changed outcomes, suggesting many patients could safely stop beta-blockers years later without increased risk.
The architecture take
For decades, it was a given: heart attack? Take beta-blockers forever. But this Lancet piece calls out the old data, noting it's from a medical era without modern revascularization, statins, or dual antiplatelet therapy. This isn't about ditching them outright after an event, but critically re-evaluating long-term use. The body's cardiovascular system adapts, and for many, the sympathetic nervous system might not need that constant dampening years later. My bet? We'll see more research on de-prescribing these drugs, especially for patients who stabilize well. It means fewer meds, fewer side effects, and maybe a more responsive nervous system for patients who no longer need the acute support. It's about getting the right dose for the right person, not just a blanket rule.